Cipla launches new anti-HIV drug Viraday

Viraday is priced at Rs 5,200 a month in India, which is a fraction of global price of approximately Rs 52,800 a month.

Pharma major Cipla on Thursday launched its fixed dose single pill anti-HIV drug Viraday priced at Rs 5,200 a month.

HT Image

Viraday is a combination of three anti-HIV drugs - Efavirenz 600 mg, Tenofovir 300 mg and Emtricitabine 200 mg, a company official said in New Delhi.

"We are offering the drug at Rs 5,200 a month, which is a fraction of the international price of approximately $1,100 (about Rs 52,800 a month)," he said.

While the company is introducing this drug in India for the first time, it is also looking at export opportunity, especially in Africa, the official said.